This is a Validated Antibody Database (VAD) review about human cytokeratin 7, based on 159 published articles (read how Labome selects the articles), using cytokeratin 7 antibody in all methods. It is aimed to help Labome visitors find the most suited cytokeratin 7 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
cytokeratin 7 synonym: CK7; K2C7; K7; SCL

Invitrogen
mouse monoclonal (OVTL12/30)
  • immunohistochemistry - paraffin section; human; 1:100; fig 3a
Invitrogen cytokeratin 7 antibody (Thermo Fisher, MA1-06316) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 3a). Sci Rep (2021) ncbi
mouse monoclonal (RCK105)
  • immunohistochemistry - paraffin section; rat; 1:200; loading ...; fig 4a
Invitrogen cytokeratin 7 antibody (Thermo Fisher, MA1-06315) was used in immunohistochemistry - paraffin section on rat samples at 1:200 (fig 4a). Cell Prolif (2021) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 2b
Invitrogen cytokeratin 7 antibody (Lab Vision, MS-343-P) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 2b). Sci Adv (2021) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 2c
Invitrogen cytokeratin 7 antibody (Invitrogen, MA5-11986) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2c). elife (2021) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 4a
Invitrogen cytokeratin 7 antibody (eBioscience, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples (fig 4a). Proc Natl Acad Sci U S A (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; rhesus macaque; 0.2 ug/ml; loading ...; fig 4g
Invitrogen cytokeratin 7 antibody (Thermo Fisher, 41-9003-82) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 0.2 ug/ml (fig 4g). Science (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 1a
Invitrogen cytokeratin 7 antibody (eBioscience, 53-9003-80) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1a). Nat Cell Biol (2020) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; fig 4, 5
Invitrogen cytokeratin 7 antibody (eBioscience, AE1/AE3) was used in immunocytochemistry on human samples (fig 4, 5). Breast Cancer Res (2019) ncbi
mouse monoclonal (PAN-CK)
  • immunocytochemistry; human; loading ...; fig s1b
In order to study the suppressive effect of DNAJB6 and Hsp70 on alpha-synuclein aggregation, Invitrogen cytokeratin 7 antibody (Thermo Fischer, MA5-13203) was used in immunocytochemistry on human samples (fig s1b). Sci Rep (2017) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunocytochemistry; mouse; fig s4e
In order to identify and characterize extended pluripotent stem cells, Invitrogen cytokeratin 7 antibody (Thermo Fisher Scientific, MA5-11986) was used in immunocytochemistry on mouse samples (fig s4e). Cell (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:150; loading ...; tbl 2
In order to describe the differences between Xp11 translocation renal cell carcinoma and the corresponding mesenchymal neoplasm, Invitrogen cytokeratin 7 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:150 (tbl 2). Hum Pathol (2017) ncbi
mouse monoclonal (AE3)
  • flow cytometry; human; loading ...
In order to examine epithelial cell populations from touch samples, Invitrogen cytokeratin 7 antibody (eBioscience, 14-900-80) was used in flow cytometry on human samples . F1000Res (2016) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; 1:5000; loading ...; fig 3b
In order to determine if the presence of the CD24-Siglec-10 in the placental bed and maternal uterine glands suggests a possible role in mediating immune tolerance at the fetal-maternal interface, Invitrogen cytokeratin 7 antibody (Thermo, OV-TL12/30) was used in immunohistochemistry - paraffin section on human samples at 1:5000 (fig 3b). Histochem Cell Biol (2017) ncbi
mouse monoclonal (OVTL12/30)
  • immunohistochemistry - paraffin section; human; 1:5000; loading ...; fig 3b
In order to determine if the presence of the CD24-Siglec-10 in the placental bed and maternal uterine glands suggests a possible role in mediating immune tolerance at the fetal-maternal interface, Invitrogen cytokeratin 7 antibody (Thermo, OV-TL12/30) was used in immunohistochemistry - paraffin section on human samples at 1:5000 (fig 3b). Histochem Cell Biol (2017) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; loading ...; fig 3d
In order to discuss a case of mixed adenoneuroendocrine carcinoma of stomach with tubular adenoma and well-differentiated neuroendocrine tumor in the primary tumor in the stomach, Invitrogen cytokeratin 7 antibody (Thermo Scientific, AE1-AE3) was used in immunohistochemistry on human samples (fig 3d). Case Rep Pathol (2016) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; 1:300; loading ...; tbl 2
In order to characterize eight cases of renal cell carcinoma cases with NONO-TFE3, Invitrogen cytokeratin 7 antibody (Zymed, OV-TL12/30) was used in immunohistochemistry - paraffin section on human samples at 1:300 (tbl 2). Mod Pathol (2017) ncbi
mouse monoclonal (OVTL12/30)
  • immunohistochemistry - paraffin section; human; 1:300; loading ...; tbl 2
In order to characterize eight cases of renal cell carcinoma cases with NONO-TFE3, Invitrogen cytokeratin 7 antibody (Zymed, OV-TL12/30) was used in immunohistochemistry - paraffin section on human samples at 1:300 (tbl 2). Mod Pathol (2017) ncbi
mouse monoclonal (OVTL12/30)
  • immunohistochemistry - paraffin section; human; 1:200; tbl 2
In order to use MAML2 staining to distinguish cases of hyalinizing clear cell carcinoma from mucoepidermoid carcinoma, Invitrogen cytokeratin 7 antibody (Thermo Scientific, OV-TL 12/30) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 2). Hum Pathol (2017) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; 1:200; tbl 2
In order to use MAML2 staining to distinguish cases of hyalinizing clear cell carcinoma from mucoepidermoid carcinoma, Invitrogen cytokeratin 7 antibody (Thermo Scientific, OV-TL 12/30) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 2). Hum Pathol (2017) ncbi
mouse monoclonal (RCK105)
  • immunohistochemistry - paraffin section; human; fig 1a
In order to correlate cytokeratin 7 and p16ink4 staining in low-grade squamous intraepithelial lesions with outcome on follow-up, Invitrogen cytokeratin 7 antibody (Thermo Fisher Scientific, RCK 105) was used in immunohistochemistry - paraffin section on human samples (fig 1a). Mod Pathol (2016) ncbi
mouse monoclonal (PAN-CK)
  • immunocytochemistry; mouse; loading ...; fig 3c
  • western blot; mouse; loading ...; fig 3d
In order to identify keratin-associated protein 5-5 as a driver of endothelial monolayer invasion, Invitrogen cytokeratin 7 antibody (Thermo Scientific, MA5-13203) was used in immunocytochemistry on mouse samples (fig 3c) and in western blot on mouse samples (fig 3d). Oncogene (2017) ncbi
mouse monoclonal (OVTL12/30)
  • immunohistochemistry; human; 1:100; tbl 4
In order to study 3 cases of uterine adenomyosis/adenomyotic cysts of the cervical stump leading to serous carcinoma, Invitrogen cytokeratin 7 antibody (Thermo, OV-TL) was used in immunohistochemistry on human samples at 1:100 (tbl 4). Diagn Pathol (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; loading ...; fig 5b
In order to investigate inflammatory responses present at the breast cancer biopsy wound site, Invitrogen cytokeratin 7 antibody (Thermo Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples (fig 5b). Breast Cancer Res Treat (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; 1:50; fig 1
In order to analyze the induction of apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue by cisplatin and doxorubicin, Invitrogen cytokeratin 7 antibody (ThermoFisher Scientific, MA5-13156) was used in immunocytochemistry on human samples at 1:50 (fig 1). Future Oncol (2016) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; 1:200; fig 4
  • western blot; human; 1:2000; fig 4
In order to analyze high-grade serous epithelial ovarian cancer cell lines that show sporadic and hereditary disease and the molecular diversity, Invitrogen cytokeratin 7 antibody (Thermo Fisher Scientific, MS-1352-P) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 4) and in western blot on human samples at 1:2000 (fig 4). Genes Cancer (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; fig s3
In order to test if the operating room environment contains human skin bacteria that could be seeding C-section born infants, Invitrogen cytokeratin 7 antibody (Molecular Probes, 985542A) was used in immunohistochemistry - paraffin section on human samples (fig s3). Microbiome (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; fig s3
In order to determine how sensitivity is restored in resistant ovarian cancer cells by targeting the Ras-MAPK pathway by miR-634, Invitrogen cytokeratin 7 antibody (Neomarkers, MS-343-P) was used in immunohistochemistry on human samples (fig s3). Mol Cancer (2015) ncbi
mouse monoclonal (PAN-CK)
  • immunohistochemistry - paraffin section; mouse; fig 4
In order to describe functionally enriched ES cell transgenics, Invitrogen cytokeratin 7 antibody (Thermo Scientific, MA5-13203) was used in immunohistochemistry - paraffin section on mouse samples (fig 4). Sci Rep (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:50; fig 3
In order to determine the desmoplastic interface in xenograft tumor in mice comprised of stromal and endothelial cells, Invitrogen cytokeratin 7 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 3). Pathol Res Pract (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; mouse; 1:100; loading ...; tbl 2
In order to investigate if conditioned medium from proliferating fibroblasts induce a subset of hematopoietic cells to become adherent fibroblast-like cells, Invitrogen cytokeratin 7 antibody (eBioscience, 41-9003) was used in immunocytochemistry on mouse samples at 1:100 (tbl 2). J Cell Physiol (2016) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; tbl 2
In order to study a northern New England hospital and increased utilization, verification, and clinical implications of immunocytochemistry, Invitrogen cytokeratin 7 antibody (Thermo Scientific, AE1/AE3) was used in immunohistochemistry on human samples (tbl 2). Diagn Cytopathol (2015) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry; human; tbl 2
In order to study a northern New England hospital and increased utilization, verification, and clinical implications of immunocytochemistry, Invitrogen cytokeratin 7 antibody (Thermo Scientific, OV-TL 12/30) was used in immunohistochemistry on human samples (tbl 2). Diagn Cytopathol (2015) ncbi
mouse monoclonal (OVTL12/30)
  • immunohistochemistry; human; tbl 2
In order to study a northern New England hospital and increased utilization, verification, and clinical implications of immunocytochemistry, Invitrogen cytokeratin 7 antibody (Thermo Scientific, OV-TL 12/30) was used in immunohistochemistry on human samples (tbl 2). Diagn Cytopathol (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; carp
In order to establish and characterize a new cell line generated from the caudal fin tissue of ornamental common carp, Invitrogen cytokeratin 7 antibody (Life Technologies, MA5-13156) was used in immunocytochemistry on carp samples . In Vitro Cell Dev Biol Anim (2015) ncbi
mouse monoclonal (AE1/AE3)
  • flow cytometry; human
  • immunocytochemistry; human; 1 ul
Invitrogen cytokeratin 7 antibody (eBioscience, 53-9003-82) was used in flow cytometry on human samples and in immunocytochemistry on human samples at 1 ul. Nanomedicine (2015) ncbi
mouse monoclonal (RCK105)
  • immunohistochemistry - paraffin section; human; fig 2
In order to discuss the different sites of human papilloma virus-induced cancer, Invitrogen cytokeratin 7 antibody (Thermo Scientific, RCK105) was used in immunohistochemistry - paraffin section on human samples (fig 2). Mod Pathol (2015) ncbi
mouse monoclonal (C11)
  • western blot; human; 1:1000
In order to develop an immunofluorescence method to assess MCT1 and MCT4 in circulating tumor cells and as them as biomarkers of AZD3965 in cancer patients, Invitrogen cytokeratin 7 antibody (Thermo Scientific, 4545) was used in western blot on human samples at 1:1000. BMC Cancer (2015) ncbi
mouse monoclonal (PAN-CK)
  • western blot; human
In order to study the impact of TNF-alpha and IL-1beta on the inflammatory phenotype of cancer-associated fibroblasts and mesenchymal stem/stromal cells, Invitrogen cytokeratin 7 antibody (Thermo Fisher Scientific, MA5-13203) was used in western blot on human samples . Stem Cell Res Ther (2015) ncbi
mouse monoclonal (AE1/AE3)
In order to generate and characterize a thymic cell line derived from Channa striatus, Invitrogen cytokeratin 7 antibody (Invitrogen, AE1/AE3) was used . In Vitro Cell Dev Biol Anim (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; domestic horse; 1:100
In order to discuss using induced pluripotent stem cells to promote wound healing in various animals, Invitrogen cytokeratin 7 antibody (Fisher Scientific, MA1-82041) was used in immunocytochemistry on domestic horse samples at 1:100. Equine Vet J (2016) ncbi
mouse monoclonal (OVTL12/30)
  • immunohistochemistry - paraffin section; human
In order to describe the clinicopathologically features of two cases of kidney mucinous tubular and spindle cell carcinoma, Invitrogen cytokeratin 7 antibody (THERMO, OV-TL12/30) was used in immunohistochemistry - paraffin section on human samples . Int J Clin Exp Pathol (2015) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human
In order to describe the clinicopathologically features of two cases of kidney mucinous tubular and spindle cell carcinoma, Invitrogen cytokeratin 7 antibody (THERMO, OV-TL12/30) was used in immunohistochemistry - paraffin section on human samples . Int J Clin Exp Pathol (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 10-20 ug/ml
In order to identify biomarkers for nasopharyngeal carcinoma, Invitrogen cytokeratin 7 antibody (Lab.Vision, Ab-1) was used in immunohistochemistry - paraffin section on human samples at 10-20 ug/ml. Asian Pac J Cancer Prev (2015) ncbi
mouse monoclonal (AE3)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig s6
In order to study how redox-dependent senescence is induced by fumarate to modify glutathione metabolism, Invitrogen cytokeratin 7 antibody (Thermo, MS-34) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s6). Nat Commun (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:100; fig s6
In order to study how redox-dependent senescence is induced by fumarate to modify glutathione metabolism, Invitrogen cytokeratin 7 antibody (Thermo, MS-34) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig s6). Nat Commun (2015) ncbi
mouse monoclonal (AE1/AE3)
  • flow cytometry; zebrafish ; 1:100; fig 5
In order to report that mice and zebrafish exposed to high-fat or high-cholesterol diets develop acute innate inflammatory responses in the intestine, Invitrogen cytokeratin 7 antibody (Thermo Fisher Scientific, MA1-82041) was used in flow cytometry on zebrafish samples at 1:100 (fig 5). Nat Commun (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 5
In order to determine the link between cell cycle control and proliferative potential of epidermal progenitor cells by the carboxy-terminus of p63, Invitrogen cytokeratin 7 antibody (ThermoFisher Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 5). Development (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
In order to assess the prognostic value of immunohistochemical markers in nonhuman primates, Invitrogen cytokeratin 7 antibody (Neo Markers, MS343) was used in immunohistochemistry - paraffin section on human samples at 1:100. Comp Med (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200; fig 3
In order to study juxtacrine signaling from macrophages and monocytes and a breast cancer stem cell niche, Invitrogen cytokeratin 7 antibody (eBioscience, 53-9003-80) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 3). Nat Cell Biol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
Invitrogen cytokeratin 7 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Hum Pathol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
Invitrogen cytokeratin 7 antibody (Thermo Fisher Scientific, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Rom J Morphol Embryol (2014) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human
In order to determine the role of myofibroblasts in salivary gland adenoid cystic carcinoma invasiveness, Invitrogen cytokeratin 7 antibody (Invitrogen, AE1/AE3) was used in immunocytochemistry on human samples . Histopathology (2015) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human
In order to test if computed tomography-lymphography distinguishes sentinel nodes from non-sentinel nodes in patients with breast cancer, Invitrogen cytokeratin 7 antibody (Thermo, AE1/AE3) was used in immunohistochemistry on human samples . BMC Med Imaging (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human
Invitrogen cytokeratin 7 antibody (Thermo Fisher, AE1/AE3) was used in immunocytochemistry on human samples . Biomed Mater (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human
In order to determine the predictive criteria of the size of nodal metastases with superparamagnetic iron oxide-enhanced MR imaging in breast cancer, Invitrogen cytokeratin 7 antibody (Thermoelectron, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples . BMC Med Imaging (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
In order to report the clinicopathological features of 9 breast malignant fibrous histiocytoma patients, Invitrogen cytokeratin 7 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). Sci Rep (2013) ncbi
mouse monoclonal (OVTL12/30)
  • immunohistochemistry - paraffin section; human; 1:150; tbl 1
In order to present the case of a 46-year-old woman with primary signet-ring cell carcinoma of the breast, Invitrogen cytokeratin 7 antibody (Invitrogen, OV-TL12/30) was used in immunohistochemistry - paraffin section on human samples at 1:150 (tbl 1). World J Surg Oncol (2013) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; 1:150; tbl 1
In order to present the case of a 46-year-old woman with primary signet-ring cell carcinoma of the breast, Invitrogen cytokeratin 7 antibody (Invitrogen, OV-TL12/30) was used in immunohistochemistry - paraffin section on human samples at 1:150 (tbl 1). World J Surg Oncol (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; human; 1:100; fig 1
Invitrogen cytokeratin 7 antibody (eBioscience, AE1/AE3) was used in immunocytochemistry on human samples at 1:100 (fig 1). PLoS ONE (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; tbl 1
In order to characterize a case of malignant ossifying fibromyxoid tumor in the tongue, Invitrogen cytokeratin 7 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry on human samples (tbl 1). Head Face Med (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; 1:200; fig 4
In order to present the third case of thymoma and the second invasive thymoma to metastasize to the cavernous sinus and adjacent to the pituitary, Invitrogen cytokeratin 7 antibody (Zymed, AE1-AE3) was used in immunohistochemistry on human samples at 1:200 (fig 4). Surg Neurol Int (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; fig 2
In order to present a case of not otherwise specified-type sarcoma with CD10 expression in the left breast, Invitrogen cytokeratin 7 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry on human samples (fig 2). Diagn Pathol (2013) ncbi
mouse monoclonal (RCK105)
  • western blot; human; 1:1000; fig 2
In order to assess the use of K8/18 in breast cancer prognosis, Invitrogen cytokeratin 7 antibody (Thermo Scientific, Pierce, RCK105) was used in western blot on human samples at 1:1000 (fig 2). PLoS ONE (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunocytochemistry; Atlantic salmon; 1:50; fig 2
In order to study cell tropism of infectious salmon anemia virus, Invitrogen cytokeratin 7 antibody (Invitrogen, AE1/AE3) was used in immunocytochemistry on Atlantic salmon samples at 1:50 (fig 2). Virol J (2013) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:100
In order to review features of choroid plexus carcinoma, Invitrogen cytokeratin 7 antibody (Invitrogen, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:100. Med Sci Monit (2012) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; mouse
In order to investigate the positioning of taste buds in circumvallate papilla and branching morphogenesis of von Ebners' gland in tongue development, Invitrogen cytokeratin 7 antibody (Thermo Scientific, MS-343) was used in immunohistochemistry - paraffin section on mouse samples . Anat Cell Biol (2011) ncbi
mouse monoclonal (C-11)
  • immunohistochemistry - paraffin section; human; 1:100
  • immunocytochemistry; human; 1:100
In order to investigate epithelial to mesenchymal transition during metastasis of pancreatic cancer, Invitrogen cytokeratin 7 antibody (Labvision, MS-149) was used in immunohistochemistry - paraffin section on human samples at 1:100 and in immunocytochemistry on human samples at 1:100. Br J Cancer (2012) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200
In order to examine the suitability of PAXgene tissue fixation for (immuno)histological methods, Invitrogen cytokeratin 7 antibody (Neomarkers, MS 343-P) was used in immunohistochemistry - paraffin section on human samples at 1:200. PLoS ONE (2011) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry; human; fig 4
In order to determine the localization and function of nucleoside transporter proteins in human syncytiotrophoblast from term placenta, Invitrogen cytokeratin 7 antibody (Zymed, OVTL 12/30) was used in immunohistochemistry on human samples (fig 4). Mol Pharmacol (2011) ncbi
mouse monoclonal (OVTL12/30)
  • immunohistochemistry; human; fig 4
In order to determine the localization and function of nucleoside transporter proteins in human syncytiotrophoblast from term placenta, Invitrogen cytokeratin 7 antibody (Zymed, OVTL 12/30) was used in immunohistochemistry on human samples (fig 4). Mol Pharmacol (2011) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry; human; 0.4 ug/ul; fig 1
In order to develop an in vitro model for experimental studies of cancer cell invasion, Invitrogen cytokeratin 7 antibody (NeoMarkers, MS-343) was used in immunohistochemistry on human samples at 0.4 ug/ul (fig 1). Eur J Oral Sci (2010) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; 1:5000
  • immunocytochemistry; human; 1:5000
In order to examine the change of caspase 8 during the fusion of villous trophoblast, Invitrogen cytokeratin 7 antibody (NeoMarkers, OV TL 12/30) was used in immunohistochemistry - paraffin section on human samples at 1:5000 and in immunocytochemistry on human samples at 1:5000. Placenta (2009) ncbi
mouse monoclonal (OVTL12/30)
  • immunohistochemistry - paraffin section; human; 1:5000
  • immunocytochemistry; human; 1:5000
In order to examine the change of caspase 8 during the fusion of villous trophoblast, Invitrogen cytokeratin 7 antibody (NeoMarkers, OV TL 12/30) was used in immunohistochemistry - paraffin section on human samples at 1:5000 and in immunocytochemistry on human samples at 1:5000. Placenta (2009) ncbi
mouse monoclonal (AE3)
  • immunohistochemistry - paraffin section; human; 1:300; tbl 2
In order to characterize feline endometrial adenocarcinomas immunohistochemically, Invitrogen cytokeratin 7 antibody (Zymed, AE3) was used in immunohistochemistry - paraffin section on human samples at 1:300 (tbl 2). J Comp Pathol (2009) ncbi
mouse monoclonal (C-11)
  • western blot; mouse
In order to develop and characterize a murine model to study enterotoxigenic Bacteroides fragilis infection, Invitrogen cytokeratin 7 antibody (Invitrogen, C-11) was used in western blot on mouse samples . Infect Immun (2009) ncbi
mouse monoclonal (C11)
  • western blot; mouse
In order to develop and characterize a murine model to study enterotoxigenic Bacteroides fragilis infection, Invitrogen cytokeratin 7 antibody (Invitrogen, C-11) was used in western blot on mouse samples . Infect Immun (2009) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:200
In order to discuss the morphological diversity of glioblastomas, Invitrogen cytokeratin 7 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:200. Cancer (2008) ncbi
mouse monoclonal (AE1/AE3)
  • western blot; human; fig 5
In order to investigate the effect of COX-2 overexpression on inhibiting proliferation, apoptosis and differentiation, Invitrogen cytokeratin 7 antibody (Lab Vision, MS-343-P) was used in western blot on human samples (fig 5). Int J Cancer (2005) ncbi
mouse monoclonal (C11)
  • western blot; mouse
In order to study the role of keratins in modulating cFlip and ERK1/2 apoptotic signaling in epithelial cells, Invitrogen cytokeratin 7 antibody (NeoMarkers, C-11) was used in western blot on mouse samples . Mol Cell Biol (2004) ncbi
mouse monoclonal (C-11)
  • western blot; mouse
In order to study the role of keratins in modulating cFlip and ERK1/2 apoptotic signaling in epithelial cells, Invitrogen cytokeratin 7 antibody (NeoMarkers, C-11) was used in western blot on mouse samples . Mol Cell Biol (2004) ncbi
mouse monoclonal (AE1/AE3)
  • immunohistochemistry - paraffin section; human; 1:80; tbl 1
In order to describe four cases of oncocytic adrenocortical carcinomas, Invitrogen cytokeratin 7 antibody (Zymed, AE1/AE3) was used in immunohistochemistry - paraffin section on human samples at 1:80 (tbl 1). Pathol Int (2004) ncbi
mouse monoclonal (AE1/AE3)
  • western blot; human; 1:1000; fig 2
In order to study how cell-matrix interactions influence the invasive behavior of a novel, primary peritoneal carcinosarcoma cell line, Invitrogen cytokeratin 7 antibody (Zymed, AE1/AE3) was used in western blot on human samples at 1:1000 (fig 2). Gynecol Oncol (2003) ncbi
Abcam
domestic rabbit monoclonal (EPR17078)
  • immunohistochemistry - frozen section; human; 1:25,000; loading ...; fig 10f
  • immunohistochemistry - frozen section; mouse; 1:5000; loading ...; fig 1i
Abcam cytokeratin 7 antibody (Abcam, AB181598) was used in immunohistochemistry - frozen section on human samples at 1:25,000 (fig 10f) and in immunohistochemistry - frozen section on mouse samples at 1:5000 (fig 1i). Sci Adv (2021) ncbi
domestic rabbit monoclonal (EPR17078)
  • immunocytochemistry; human; 1:100; loading ...; fig 1l
Abcam cytokeratin 7 antibody (Abcam, ab181598) was used in immunocytochemistry on human samples at 1:100 (fig 1l). Sci Rep (2021) ncbi
domestic rabbit monoclonal (EPR17078)
  • immunohistochemistry; mouse; 1:1000; loading ...; fig 1s1b
Abcam cytokeratin 7 antibody (Abcam, ab181598) was used in immunohistochemistry on mouse samples at 1:1000 (fig 1s1b). elife (2021) ncbi
domestic rabbit monoclonal (EPR1619Y)
  • immunocytochemistry; human; 1:100; fig 2d
Abcam cytokeratin 7 antibody (Abcam, ab68459) was used in immunocytochemistry on human samples at 1:100 (fig 2d). Science (2021) ncbi
mouse monoclonal (RCK105)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 5f
Abcam cytokeratin 7 antibody (Abcam, ab9021) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 5f). Life Sci Alliance (2020) ncbi
domestic rabbit monoclonal (EPR17078)
  • immunohistochemistry - paraffin section; mouse; 1:1000; loading ...; fig 1a
Abcam cytokeratin 7 antibody (Abcam, ab181598) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000 (fig 1a). Stem Cell Res Ther (2020) ncbi
domestic rabbit monoclonal (EPR17078)
  • western blot; mouse; 1:1500; loading ...; fig s2i
Abcam cytokeratin 7 antibody (Abcam, Ab181598) was used in western blot on mouse samples at 1:1500 (fig s2i). Nat Commun (2020) ncbi
domestic rabbit monoclonal (EPR17078)
  • immunohistochemistry; mouse; loading ...; fig s2a
Abcam cytokeratin 7 antibody (Abcam, EPR17078) was used in immunohistochemistry on mouse samples (fig s2a). Nature (2019) ncbi
domestic rabbit monoclonal (EPR1619Y)
  • flow cytometry; human; loading ...; fig 4c
Abcam cytokeratin 7 antibody (abcam, ab185048) was used in flow cytometry on human samples (fig 4c). Cell (2019) ncbi
domestic rabbit monoclonal (EPR17078)
  • western blot; human; fig 4a
Abcam cytokeratin 7 antibody (Abcam, ab181598) was used in western blot on human samples (fig 4a). J Exp Med (2019) ncbi
domestic rabbit monoclonal (EPR17078)
  • immunohistochemistry; mouse; loading ...; fig 4c
Abcam cytokeratin 7 antibody (Abcam, ab181598) was used in immunohistochemistry on mouse samples (fig 4c). Science (2019) ncbi
mouse monoclonal (RCK105)
  • immunohistochemistry; domestic rabbit; fig 6a
Abcam cytokeratin 7 antibody (Abcam, ab9021) was used in immunohistochemistry on domestic rabbit samples (fig 6a). Stem Cell Res Ther (2017) ncbi
domestic rabbit monoclonal (EPR17078)
  • immunohistochemistry - paraffin section; rat; loading ...; fig 2c
Abcam cytokeratin 7 antibody (Abcam, ab181598) was used in immunohistochemistry - paraffin section on rat samples (fig 2c). Toxicology (2017) ncbi
domestic rabbit monoclonal (SP52)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 4
Abcam cytokeratin 7 antibody (Abcam, ab183344) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 4). Oncol Lett (2016) ncbi
domestic rabbit monoclonal (EPR17078)
  • immunohistochemistry - paraffin section; rat; loading ...; fig 8a
In order to investigate the feasibility of a decellularized liver construct to support growth of functional multilineage cells, Abcam cytokeratin 7 antibody (Abcam, ab181598) was used in immunohistochemistry - paraffin section on rat samples (fig 8a). Organogenesis (2017) ncbi
mouse monoclonal (RCK105)
  • immunohistochemistry; human; 1:500; fig 2
Abcam cytokeratin 7 antibody (Abcam, ab-9021) was used in immunohistochemistry on human samples at 1:500 (fig 2). Oncol Lett (2016) ncbi
domestic rabbit monoclonal (EPR17078)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 2a
Abcam cytokeratin 7 antibody (Abcam, ab181598) was used in immunohistochemistry - paraffin section on mouse samples (fig 2a). Reprod Biol (2016) ncbi
mouse monoclonal (RCK105)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3c
Abcam cytokeratin 7 antibody (Abcam, ab9021) was used in immunohistochemistry - paraffin section on mouse samples (fig 3c). Sci Rep (2016) ncbi
mouse monoclonal (RCK105)
  • immunohistochemistry; mouse; fig 2
Abcam cytokeratin 7 antibody (Abcam, ab9021) was used in immunohistochemistry on mouse samples (fig 2). Oncotarget (2015) ncbi
mouse monoclonal (RCK105)
  • western blot; rat; 1:200; fig 2
In order to elucidate ketamine-induced ulcerative cystitis and bladder apoptosis in association with oxidative stress mediated by mitochondria and the endoplasmic reticulum, Abcam cytokeratin 7 antibody (Abcam, ab9021) was used in western blot on rat samples at 1:200 (fig 2). Am J Physiol Renal Physiol (2015) ncbi
mouse monoclonal (RCK105)
  • immunocytochemistry; human; 1:300
Abcam cytokeratin 7 antibody (Abcam, ab9021) was used in immunocytochemistry on human samples at 1:300. J Biol Chem (2014) ncbi
Santa Cruz Biotechnology
mouse monoclonal (C46)
  • immunohistochemistry - paraffin section; mouse; 1:200; fig 1
In order to learn the requirement for epithelial cell fate decision in the lower mullerian duct by FGFR2IIIb-MAPK activity, Santa Cruz Biotechnology cytokeratin 7 antibody (Santa Cruz, sc-8421) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 1). Mol Endocrinol (2016) ncbi
mouse monoclonal (LP1K)
  • immunocytochemistry; human; 1:200; fig 5
Santa Cruz Biotechnology cytokeratin 7 antibody (Santa Cruz, sc-53263) was used in immunocytochemistry on human samples at 1:200 (fig 5). Nat Commun (2016) ncbi
mouse monoclonal (RCK105)
  • immunohistochemistry; rat; 1:150; fig 2
Santa Cruz Biotechnology cytokeratin 7 antibody (Santa Cruz, SC-23876) was used in immunohistochemistry on rat samples at 1:150 (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (RCK105)
  • immunohistochemistry - paraffin section; human; 1:100
Santa Cruz Biotechnology cytokeratin 7 antibody (Santa Cruz Biotechnologies, clone RCK105) was used in immunohistochemistry - paraffin section on human samples at 1:100. Cell Death Differ (2015) ncbi
mouse monoclonal (RCK105)
  • immunocytochemistry; human; fig 4
  • western blot; human; fig 4
Santa Cruz Biotechnology cytokeratin 7 antibody (Santa Cruz, sc-23876) was used in immunocytochemistry on human samples (fig 4) and in western blot on human samples (fig 4). J Biol Chem (2015) ncbi
mouse monoclonal (5F282)
  • western blot; mouse; fig 7
Santa Cruz Biotechnology cytokeratin 7 antibody (Santa Cruz, sc-70936) was used in western blot on mouse samples (fig 7). PLoS ONE (2014) ncbi
Novus Biologicals
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:500; loading ...; fig 6d
Novus Biologicals cytokeratin 7 antibody (Novus, NBP1-88080) was used in immunohistochemistry - paraffin section on mouse samples at 1:500 (fig 6d). Nat Commun (2019) ncbi
Dako
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry; rhesus macaque; 1:1000; fig 4a
Dako cytokeratin 7 antibody (Dako, M7018) was used in immunohistochemistry on rhesus macaque samples at 1:1000 (fig 4a). BMC Biol (2021) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry; rat; 1:100; loading ...; fig s9a
Dako cytokeratin 7 antibody (Dako Cytomation, M7018) was used in immunohistochemistry on rat samples at 1:100 (fig s9a). Nat Commun (2021) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunocytochemistry; human; fig 6g
Dako cytokeratin 7 antibody (DAKO, M7018) was used in immunocytochemistry on human samples (fig 6g). Cell Stem Cell (2021) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; 1:300; loading ...; fig 6
Dako cytokeratin 7 antibody (DAKO, OV-TL 12/30) was used in immunohistochemistry - paraffin section on human samples at 1:300 (fig 6). Oncotarget (2020) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 6a
Dako cytokeratin 7 antibody (Agilent Dako, M7018) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 6a). J Biomed Sci (2020) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry; human; 1:50; loading ...; fig 1f
Dako cytokeratin 7 antibody (DAKO, M7018) was used in immunohistochemistry on human samples at 1:50 (fig 1f). J Clin Med (2019) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry; human; 1:100; loading ...; fig 2d
Dako cytokeratin 7 antibody (DAKO, M7018) was used in immunohistochemistry on human samples at 1:100 (fig 2d). Endocrinology (2019) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; dogs; 1:200; loading ...; fig 3e
Dako cytokeratin 7 antibody (Dako, OV-TL 12/30) was used in immunohistochemistry - paraffin section on dogs samples at 1:200 (fig 3e). J Vet Med Sci (2019) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig s2e
Dako cytokeratin 7 antibody (Agilent Technologies, M7018) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig s2e). PLoS ONE (2017) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
Dako cytokeratin 7 antibody (Dako, OV-TL 12/30) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). Hum Pathol (2017) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry; mouse; loading ...; fig 3c
Dako cytokeratin 7 antibody (Dako, OV-TL 12/30) was used in immunohistochemistry on mouse samples (fig 3c). Development (2017) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; dogs; loading ...; fig st6
In order to outline the protocols for antibodies used for immunohistochemical studies, Dako cytokeratin 7 antibody (Dako, M7018) was used in immunohistochemistry - paraffin section on dogs samples (fig st6). J Toxicol Pathol (2017) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry; mouse; 1:500; loading ...; fig 3f
In order to report that hepatocytes rapidly upregulate NF- kB and Smad2/3 activity, and repress Notch signaling, Dako cytokeratin 7 antibody (Dako, M7018) was used in immunohistochemistry on mouse samples at 1:500 (fig 3f). Sci Rep (2017) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry; dogs; 1:100; fig S1b,S2b,S3b,S4b
In order to characterize an atypical cutaneous tumor of a 9-year-old mixed breed female dog, Dako cytokeratin 7 antibody (Dako, OV-TL 12/30) was used in immunohistochemistry on dogs samples at 1:100 (fig S1b,S2b,S3b,S4b). J Vet Med Sci (2017) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 10h
In order to describe how SCN4B and beta4 regulate cancer cell invasiveness and tumor progression, Dako cytokeratin 7 antibody (Dakocytomation, OV-TL 12/30) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 10h). Nat Commun (2016) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunocytochemistry; dogs; 1:100; tbl 5
In order to establish canine mammary tissue derived cell lines and study claudin expression, Dako cytokeratin 7 antibody (Dako, OV-TL12/30) was used in immunocytochemistry on dogs samples at 1:100 (tbl 5). Int J Mol Sci (2016) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunocytochemistry; human; fig 2a
Dako cytokeratin 7 antibody (Dako, OV-TL 12/30) was used in immunocytochemistry on human samples (fig 2a). BMC Cancer (2016) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; 1.96 ug/ml; fig 1
Dako cytokeratin 7 antibody (Dako, OV-TL12/30) was used in immunohistochemistry - paraffin section on human samples at 1.96 ug/ml (fig 1). Sci Rep (2016) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry; human; 1:100; loading ...; fig 1a
Dako cytokeratin 7 antibody (Dako, M7018) was used in immunohistochemistry on human samples at 1:100 (fig 1a). PLoS ONE (2016) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry; human; 0.256 ug/ml; tbl 2
In order to measure the extent of squamous metaplasia in bronchial biopsies and correlate it to the presence of chronic obstructive pulmonary disease, Dako cytokeratin 7 antibody (Dako, M7018) was used in immunohistochemistry on human samples at 0.256 ug/ml (tbl 2). PLoS ONE (2016) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; fig 2
Dako cytokeratin 7 antibody (Dako, OV-TL 12/30) was used in immunohistochemistry - paraffin section on human samples (fig 2). J Exp Clin Cancer Res (2016) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; tbl 2
In order to present the clinicopathological features of nine cases of renal cell carcinoma metastatic to the ovary or the fallopian tube, Dako cytokeratin 7 antibody (Dako, OV-TL) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). Hum Pathol (2016) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; tbl 3
In order to study the role of LFABP loss in hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas, Dako cytokeratin 7 antibody (Dako, OV-TL 12/30) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 3). Mod Pathol (2016) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; 1:1000; fig 1c
Dako cytokeratin 7 antibody (Dako, OV-TL 12/30) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 1c). Ann Oncol (2016) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; tbl 2
In order to characterize 21 cases of biphasic squamoid alveolar renal cell carcinoma, Dako cytokeratin 7 antibody (DakoCytomation, OV-TL12/30) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 2). Am J Surg Pathol (2016) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...
In order to characterize and present the first case of fibroblastic reticular cell tumor of the breast, Dako cytokeratin 7 antibody (Dako, Ov-TL 12/30) was used in immunohistochemistry - paraffin section on human samples at 1:100. Exp Ther Med (2016) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 3a
Dako cytokeratin 7 antibody (Dako, OVTL12/30) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 3a). Histopathology (2016) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry; human; 1:300; tbl 1
Dako cytokeratin 7 antibody (Dako, OV-TL 12/30) was used in immunohistochemistry on human samples at 1:300 (tbl 1). Oral Surg Oral Med Oral Pathol Oral Radiol (2016) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 1c
In order to describe a rare case of ALK-rearranged lung squamous cell carcinoma with response to crizotinib therapy, Dako cytokeratin 7 antibody (Dako, OV-TL 12/30) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1c). Lung Cancer (2016) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; 1:1000; fig 2d
Dako cytokeratin 7 antibody (Dako, M701801) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 2d). Head Neck Pathol (2016) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; fig 7
Dako cytokeratin 7 antibody (dako, M7018) was used in immunohistochemistry - paraffin section on human samples (fig 7). Oncotarget (2015) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; dogs; 1:50; fig 1
In order to study canine hepatic progenitor cell niche activation by enhanced Wnt/beta-catenin and Notch signaling, Dako cytokeratin 7 antibody (Dako, OV-TL 12/30) was used in immunohistochemistry - paraffin section on dogs samples at 1:50 (fig 1). BMC Vet Res (2014) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; 1:1000; tbl 3
In order to distinguish primary from secondary mucinous ovarian tumors by intratumoral lymphovascular density, Dako cytokeratin 7 antibody (DAKO, OV-TL 12/30) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (tbl 3). Clinics (Sao Paulo) (2014) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human
In order to characterize two cases of primary thymic adenocarcinoma with enteric differentiation, Dako cytokeratin 7 antibody (Dako, clone OV-TL 12/30) was used in immunohistochemistry - paraffin section on human samples . Am J Surg Pathol (2015) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; ready-to-use
Dako cytokeratin 7 antibody (Dako, OV-TL 12/30) was used in immunohistochemistry - paraffin section on human samples at ready-to-use. Case Rep Pathol (2014) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; 1:100
Dako cytokeratin 7 antibody (DAKO, OV-TL12/30) was used in immunohistochemistry - paraffin section on human samples at 1:100. Cancer Med (2015) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; 247 mg/l
Dako cytokeratin 7 antibody (DAKO, OV-TL 12/30) was used in immunohistochemistry - paraffin section on human samples at 247 mg/l. Oncotarget (2014) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry; human; 1:200
In order to describe the histological features canalicular adenoma, Dako cytokeratin 7 antibody (Dako, OV-TL-12/30) was used in immunohistochemistry on human samples at 1:200. Head Neck Pathol (2015) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human
Dako cytokeratin 7 antibody (DAKO, OV-TL 12/30) was used in immunohistochemistry - paraffin section on human samples . Reproduction (2014) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunocytochemistry; human; 1:50
Dako cytokeratin 7 antibody (Dako, M7018) was used in immunocytochemistry on human samples at 1:50. PLoS ONE (2014) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry; human; 1:50
Dako cytokeratin 7 antibody (Dako, OV-TL 12/30) was used in immunohistochemistry on human samples at 1:50. Pathol Res Pract (2014) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; 1:100
In order to investigate the signalling pathways involved in the development of invasive trophoblasts, Dako cytokeratin 7 antibody (Dako, OV-TL 12/30) was used in immunohistochemistry - paraffin section on human samples at 1:100. Mol Hum Reprod (2014) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; 1:200
In order to reoprt on a case of an unusual primary gastric Merkel cell carcinoma, Dako cytokeratin 7 antibody (Dako, OV-TL 12/30) was used in immunohistochemistry - paraffin section on human samples at 1:200. Hum Pathol (2014) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; 1:1000
Dako cytokeratin 7 antibody (Dako, M7018) was used in immunohistochemistry - paraffin section on human samples at 1:1000. Biol Reprod (2014) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry; human; fig 1
In order to identify and characterize BRAF mutation from patients with metanephric adenomas, Dako cytokeratin 7 antibody (Dako, OV-TL 12/30) was used in immunohistochemistry on human samples (fig 1). Cancer Genet (2013) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunocytochemistry; human; 1:50; fig 4b
  • western blot; human; 1:700; fig 4a
Dako cytokeratin 7 antibody (Dako, OV-TL12/30) was used in immunocytochemistry on human samples at 1:50 (fig 4b) and in western blot on human samples at 1:700 (fig 4a). Biochimie (2014) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry; human
In order to study salivary duct carcinoma with rhabdoid features, Dako cytokeratin 7 antibody (DakoCytomation, OV-TL-12/30) was used in immunohistochemistry on human samples . Head Neck (2014) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry; human; 1:200; loading ...
Dako cytokeratin 7 antibody (Dako, OV-TL 12/30) was used in immunohistochemistry on human samples at 1:200. Hum Pathol (2013) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry; human; 2 ug/ml
Dako cytokeratin 7 antibody (Dako, M7018) was used in immunohistochemistry on human samples at 2 ug/ml. Reprod Sci (2014) ncbi
mouse monoclonal (OV-TL 12/30)
  • flow cytometry; human
Dako cytokeratin 7 antibody (Dako, M7018) was used in flow cytometry on human samples . Endocrinology (2013) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human
In order to investigate the polypoid PEComa in the gastrointestinal tract, Dako cytokeratin 7 antibody (Dako, OV-TL 12/30) was used in immunohistochemistry - paraffin section on human samples . Am J Surg Pathol (2009) ncbi
Leica Biosystems
monoclonal (RN7)
  • immunohistochemistry; pigs ; 1:100; fig 5
Leica Biosystems cytokeratin 7 antibody (Leica Biosystems, PA0943) was used in immunohistochemistry on pigs samples at 1:100 (fig 5). Cells (2021) ncbi
monoclonal (RN7)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 3
Leica Biosystems cytokeratin 7 antibody (Nova Castra, RN7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 3). Hum Pathol (2017) ncbi
monoclonal
  • immunohistochemistry - paraffin section; human; 1:50; loading ...
Leica Biosystems cytokeratin 7 antibody (Leica Biosystems, NCL-L-CK7-OVTL) was used in immunohistochemistry - paraffin section on human samples at 1:50. Oncol Lett (2016) ncbi
monoclonal (RN7)
  • immunohistochemistry; human; loading ...; fig 4a
In order to discuss a case of mixed adenoneuroendocrine carcinoma of stomach with tubular adenoma and well-differentiated neuroendocrine tumor in the primary tumor in the stomach, Leica Biosystems cytokeratin 7 antibody (Leica, RN7) was used in immunohistochemistry on human samples (fig 4a). Case Rep Pathol (2016) ncbi
monoclonal
  • immunohistochemistry - paraffin section; human; 1:30; tbl 2
Leica Biosystems cytokeratin 7 antibody (Novocastra, NCL-L-CK7-OVTL) was used in immunohistochemistry - paraffin section on human samples at 1:30 (tbl 2). Int J Mol Sci (2016) ncbi
monoclonal (RN7)
  • immunohistochemistry - paraffin section; domestic sheep; fig 12
In order to characterize the experimental transmission of bighorn sheep sinus tumors to domestic sheep and bighorn sheep (ovis canadensis canadensis), Leica Biosystems cytokeratin 7 antibody (Leica Biosystems, PA0943) was used in immunohistochemistry - paraffin section on domestic sheep samples (fig 12). Vet Pathol (2016) ncbi
mouse monoclonal (OV-TL 12/30)
  • immunohistochemistry - paraffin section; human; 1:120; loading ...; tbl 1
In order to present a case of cellular spindle cell neoplasm with features of both cellular schwannoma and pseudoglandular schwannoma, Leica Biosystems cytokeratin 7 antibody (Leica, OVTL-12/30) was used in immunohistochemistry - paraffin section on human samples at 1:120 (tbl 1). Am J Dermatopathol (2016) ncbi
monoclonal (RN7)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1
In order to report a unique case of familial adenomatous polyposis, Leica Biosystems cytokeratin 7 antibody (Novocastra, RN7) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1). Pathol Res Pract (2016) ncbi
monoclonal
  • immunohistochemistry - paraffin section; human; 1:500
In order to study the expression of zonula occludens-1 and occludin in the bladder urothelium of patients with interstitial cystitis/painful bladder syndrome, Leica Biosystems cytokeratin 7 antibody (Novocastra, NCL-L-CK7-OVTL) was used in immunohistochemistry - paraffin section on human samples at 1:500. J Formos Med Assoc (2014) ncbi
monoclonal (RN7)
  • immunohistochemistry - paraffin section; human
Leica Biosystems cytokeratin 7 antibody (Leica, RN7) was used in immunohistochemistry - paraffin section on human samples . Int J Gynecol Pathol (2014) ncbi
BD Biosciences
mouse monoclonal (RCK105)
  • mass cytometry; human; loading ...; fig 3a
BD Biosciences cytokeratin 7 antibody (BD Biosciences, 550507) was used in mass cytometry on human samples (fig 3a). Cell (2019) ncbi
mouse monoclonal (RCK105)
  • flow cytometry; human; loading ...; fig 1B
In order to infer that polychlorinated biphenyls impart pregnancy disruptive functions by activating the Notch/Dll pathway and by inducing anti-angiogenic effects at the maternal-fetal interface, BD Biosciences cytokeratin 7 antibody (BD Biosciences, RCK105) was used in flow cytometry on human samples (fig 1B). Sci Rep (2017) ncbi
mouse monoclonal (RCK105)
  • immunohistochemistry - paraffin section; mouse; 1:200
BD Biosciences cytokeratin 7 antibody (BD Bioscience, 550 507) was used in immunohistochemistry - paraffin section on mouse samples at 1:200. Endocrinology (2015) ncbi
Articles Reviewed
  1. Cham T, Ibtisham F, Fayaz M, Honaramooz A. Generation of a Highly Biomimetic Organoid, Including Vasculature, Resembling the Native Immature Testis Tissue. Cells. 2021;10: pubmed publisher
  2. Adori C, Daraio T, Kuiper R, Barde S, Horvathova L, Yoshitake T, et al. Disorganization and degeneration of liver sympathetic innervations in nonalcoholic fatty liver disease revealed by 3D imaging. Sci Adv. 2021;7: pubmed publisher
  3. Sato M, Inohaya A, Yasuda E, Mogami H, Chigusa Y, Kawasaki K, et al. Three-dimensional human placenta-like bud synthesized from induced pluripotent stem cells. Sci Rep. 2021;11:14167 pubmed publisher
  4. Rosenkrantz J, Gaffney J, Roberts V, Carbone L, CHAVEZ S. Transcriptomic analysis of primate placentas and novel rhesus trophoblast cell lines informs investigations of human placentation. BMC Biol. 2021;19:127 pubmed publisher
  5. Wang X, Li Z, Shao Q, Zhang C, Wang J, Han Z, et al. The intact parasympathetic nerve promotes submandibular gland regeneration through ductal cell proliferation. Cell Prolif. 2021;54:e13078 pubmed publisher
  6. Janmaat V, Nesteruk K, Spaander M, Verhaar A, Yu B, Silva R, et al. HOXA13 in etiology and oncogenic potential of Barrett's esophagus. Nat Commun. 2021;12:3354 pubmed publisher
  7. Barthet V, Brucoli M, Ladds M, Nössing C, Kiourtis C, Baudot A, et al. Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver. Sci Adv. 2021;7: pubmed publisher
  8. Huang L, Desai R, Conrad D, Leite N, Akshinthala D, Lim C, et al. Commitment and oncogene-induced plasticity of human stem cell-derived pancreatic acinar and ductal organoids. Cell Stem Cell. 2021;28:1090-1104.e6 pubmed publisher
  9. Hankeova S, Salplachta J, Zikmund T, Kavkova M, Van Hul N, Brinek A, et al. DUCT reveals architectural mechanisms contributing to bile duct recovery in a mouse model for Alagille syndrome. elife. 2021;10: pubmed publisher
  10. Sampaziotis F, Muraro D, Tysoe O, Sawiak S, Beach T, Godfrey E, et al. Cholangiocyte organoids can repair bile ducts after transplantation in the human liver. Science. 2021;371:839-846 pubmed publisher
  11. Biasci D, Smoragiewicz M, Connell C, Wang Z, Gao Y, Thaventhiran J, et al. CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response. Proc Natl Acad Sci U S A. 2020;117:28960-28970 pubmed publisher
  12. Chandrashekar A, Liu J, Martinot A, McMahan K, Mercado N, Peter L, et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020;: pubmed publisher
  13. Cohen B, Tempelhof H, Raz T, Oren R, Nicenboim J, Bochner F, et al. BACH family members regulate angiogenesis and lymphangiogenesis by modulating VEGFC expression. Life Sci Alliance. 2020;3: pubmed publisher
  14. Mitrofanova L, Hazratov A, Galkovsky B, Gorshkov A, Bobkov D, Gulyaev D, et al. Morphological and immunophenotypic characterization of perivascular interstitial cells in human glioma: Telocytes, pericytes, and mixed immunophenotypes. Oncotarget. 2020;11:322-346 pubmed publisher
  15. Hou M, Han J, Li G, Kwon M, Jiang J, Emani S, et al. Multipotency of mouse trophoblast stem cells. Stem Cell Res Ther. 2020;11:55 pubmed publisher
  16. Gaglia G, Rashid R, Yapp C, Joshi G, Li C, Lindquist S, et al. HSF1 phase transition mediates stress adaptation and cell fate decisions. Nat Cell Biol. 2020;22:151-158 pubmed publisher
  17. Hsu H, Liu C, Lin J, Hsu T, Hsu J, Li A, et al. Involvement of collagen XVII in pluripotency gene expression and metabolic reprogramming of lung cancer stem cells. J Biomed Sci. 2020;27:5 pubmed publisher
  18. Wang G, Xu J, Zhao J, Yin W, Liu D, Chen W, et al. Arf1-mediated lipid metabolism sustains cancer cells and its ablation induces anti-tumor immune responses in mice. Nat Commun. 2020;11:220 pubmed publisher
  19. Quach C, Song Y, Guo H, Li S, Maazi H, Fung M, et al. A truncating mutation in the autophagy gene UVRAG drives inflammation and tumorigenesis in mice. Nat Commun. 2019;10:5681 pubmed publisher
  20. Benechet A, De Simone G, Di Lucia P, Cilenti F, Barbiera G, Le Bert N, et al. Dynamics and genomic landscape of CD8+ T cells undergoing hepatic priming. Nature. 2019;574:200-205 pubmed publisher
  21. Ramani V, Lemaire C, Triboulet M, Casey K, Heirich K, Renier C, et al. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer. Breast Cancer Res. 2019;21:98 pubmed publisher
  22. Kim Y, You H, Park S, Kim M, Chae H, Park J, et al. A Mutation in ZNF143 as a Novel Candidate Gene for Endothelial Corneal Dystrophy. J Clin Med. 2019;8: pubmed publisher
  23. Haider S, Gamperl M, Burkard T, Kunihs V, Kaindl U, Junttila S, et al. Estrogen Signaling Drives Ciliogenesis in Human Endometrial Organoids. Endocrinology. 2019;160:2282-2297 pubmed publisher
  24. Ligorio M, Sil S, Malagon Lopez J, Nieman L, Misale S, Di Pilato M, et al. Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer. Cell. 2019;: pubmed publisher
  25. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  26. Gao Q, Yang Z, Xu S, Li X, Yang X, Jin P, et al. Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer. J Exp Med. 2019;216:688-703 pubmed publisher
  27. Lee S, Ji H, Baek S, Lee A, Kim M, Park S, et al. Feline-type cystic basal cell tumor filled with abundant melanin pigment-rich fluid in a dog. J Vet Med Sci. 2019;81:269-273 pubmed publisher
  28. Nicetto D, Donahue G, Jain T, Peng T, Sidoli S, Sheng L, et al. H3K9me3-heterochromatin loss at protein-coding genes enables developmental lineage specification. Science. 2019;363:294-297 pubmed publisher
  29. Li Y, Yang Y, Yang L, Zeng Y, Gao X, Xu H. Poly(ethylene glycol)-modified silk fibroin membrane as a carrier for limbal epithelial stem cell transplantation in a rabbit LSCD model. Stem Cell Res Ther. 2017;8:256 pubmed publisher
  30. Aprile F, Källstig E, Limorenko G, Vendruscolo M, Ron D, Hansen C. The molecular chaperones DNAJB6 and Hsp70 cooperate to suppress α-synuclein aggregation. Sci Rep. 2017;7:9039 pubmed publisher
  31. Zhao G, Xu D, Yuan Z, Jiang Z, Zhou W, Li Z, et al. 8-Methoxypsoralen disrupts MDR3-mediated phospholipids efflux and bile acid homeostasis and its relevance to hepatotoxicity. Toxicology. 2017;386:40-48 pubmed publisher
  32. Posenato I, Caliò A, Segala D, Sgroi S, Polara A, Brunelli M, et al. Primary seminal vesicle carcinoma. The usefulness of PAX8 immunohistochemical expression for the differential diagnosis. Hum Pathol. 2017;69:123-128 pubmed publisher
  33. Yang Y, Liu B, Xu J, Wang J, Wu J, Shi C, et al. Derivation of Pluripotent Stem Cells with In Vivo Embryonic and Extraembryonic Potency. Cell. 2017;169:243-257.e25 pubmed publisher
  34. Wang X, Xia Q, Ni H, Ye S, Li R, Wang X, et al. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion. Hum Pathol. 2017;63:190-200 pubmed publisher
  35. Chen J, Borges M. Histopathology and enhanced detection of tumor invasion of peritoneal membranes. PLoS ONE. 2017;12:e0173833 pubmed publisher
  36. Braxton D, Saxe D, Damjanov N, Stashek K, Shroff S, Morrissette J, et al. Molecular and cytogenomic profiling of hepatic adenocarcinoma expressing inhibinA, a mimicker of neuroendocrine tumors: proposal to reclassify as "cholangioblastic variant of intrahepatic cholangiocarcinoma". Hum Pathol. 2017;62:232-241 pubmed publisher
  37. Koike H, Zhang R, Ueno Y, Sekine K, Zheng Y, Takebe T, et al. Nutritional modulation of mouse and human liver bud growth through a branched-chain amino acid metabolism. Development. 2017;144:1018-1024 pubmed publisher
  38. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed publisher
  39. Delhove J, Buckley S, Perocheau D, Karda R, Arbuthnot P, Henderson N, et al. Longitudinal in vivo bioimaging of hepatocyte transcription factor activity following cholestatic liver injury in mice. Sci Rep. 2017;7:41874 pubmed publisher
  40. Watanabe K, Chambers J, Uchida K, Nibe K, Ushio N, Horiuchi N, et al. A cutaneous mixed tumor in a dog. J Vet Med Sci. 2017;79:670-673 pubmed publisher
  41. Kwon Y, Stanciu C, Philpott M, Ehrhardt C. Flow cytometry dataset for cells collected from touched surfaces. F1000Res. 2016;5:390 pubmed publisher
  42. Fasano M, Della Corte C, Vicidomini G, Scotti V, Rambaldi P, Fiorelli A, et al. Small bowel metastasis from pancreatic cancer in a long-term survival patient with synchronous advanced malignant pleural mesothelioma: A case report and literature review. Oncol Lett. 2016;12:4505-4509 pubmed publisher
  43. Moro A, Foresta E, Gasparini G, Pelo S, Forcione M, Cristallini E, et al. Ameloblastic carcinoma of the maxilla: A case report and an updated review of the literature. Oncol Lett. 2016;12:4339-4350 pubmed publisher
  44. Kalkunte S, Huang Z, Lippe E, Kumar S, Robertson L, Sharma S. Polychlorinated biphenyls target Notch/Dll and VEGF R2 in the mouse placenta and human trophoblast cell lines for their anti-angiogenic effects. Sci Rep. 2017;7:39885 pubmed publisher
  45. Hassanein W, Uluer M, Langford J, Woodall J, Cimeno A, Dhru U, et al. Recellularization via the bile duct supports functional allogenic and xenogenic cell growth on a decellularized rat liver scaffold. Organogenesis. 2017;13:16-27 pubmed publisher
  46. Sammar M, Siwetz M, Meiri H, Fleming V, Altevogt P, Huppertz B. Expression of CD24 and Siglec-10 in first trimester placenta: implications for immune tolerance at the fetal-maternal interface. Histochem Cell Biol. 2017;147:565-574 pubmed publisher
  47. De Luca Johnson J, Zenali M. A Previously Undescribed Presentation of Mixed Adenoneuroendocrine Carcinoma. Case Rep Pathol. 2016;2016:9063634 pubmed
  48. Xia Q, Wang Z, Chen N, Gan H, Teng X, Shi S, et al. Xp11.2 translocation renal cell carcinoma with NONO-TFE3 gene fusion: morphology, prognosis, and potential pitfall in detecting TFE3 gene rearrangement. Mod Pathol. 2017;30:416-426 pubmed publisher
  49. Bon E, Driffort V, Gradek F, Martinez Caceres C, Anchelin M, Pelegrin P, et al. SCN4B acts as a metastasis-suppressor gene preventing hyperactivation of cell migration in breast cancer. Nat Commun. 2016;7:13648 pubmed publisher
  50. Hsieh M, Wang H, Lee Y, Ko J, Chang Y. Reevaluation of MAML2 fusion-negative mucoepidermoid carcinoma: a subgroup being actually hyalinizing clear cell carcinoma of the salivary gland with EWSR1 translocation. Hum Pathol. 2017;61:9-18 pubmed publisher
  51. Hammer S, Becker A, Rateitschak K, Mohr A, Lüder Ripoli F, Hennecke S, et al. Longitudinal Claudin Gene Expression Analyses in Canine Mammary Tissues and Thereof Derived Primary Cultures and Cell Lines. Int J Mol Sci. 2016;17: pubmed
  52. Huang E, Tomic M, Hanamornroongruang S, Meserve E, Herfs M, Crum C. p16ink4 and cytokeratin 7 immunostaining in predicting HSIL outcome for low-grade squamous intraepithelial lesions: a case series, literature review and commentary. Mod Pathol. 2016;29:1501-1510 pubmed publisher
  53. Sui X, Hu Y, Zhang C, Pan H, Li D. Prostate cancer metastasis to the distal phalanx of the left hallux: The first confirmed case and literature review. Oncol Lett. 2016;12:1074-1078 pubmed
  54. Pailler E, Oulhen M, Billiot F, Galland A, Auger N, Faugeroux V, et al. Method for semi-automated microscopy of filtration-enriched circulating tumor cells. BMC Cancer. 2016;16:477 pubmed publisher
  55. Berens E, Sharif G, Schmidt M, Yan G, Shuptrine C, Weiner L, et al. Keratin-associated protein 5-5 controls cytoskeletal function and cancer cell vascular invasion. Oncogene. 2017;36:593-605 pubmed publisher
  56. Meinhardt G, Saleh L, Otti G, Haider S, Velicky P, Fiala C, et al. Wingless ligand 5a is a critical regulator of placental growth and survival. Sci Rep. 2016;6:28127 pubmed publisher
  57. Carpino G, Nobili V, Renzi A, De Stefanis C, Stronati L, Franchitto A, et al. Macrophage Activation in Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) Correlates with Hepatic Progenitor Cell Response via Wnt3a Pathway. PLoS ONE. 2016;11:e0157246 pubmed publisher
  58. Lu B, Chen Q, Zhang X, Cheng L. Serous carcinoma arising from uterine adenomyosis/adenomyotic cyst of the cervical stump: a report of 3 cases. Diagn Pathol. 2016;11:46 pubmed publisher
  59. Szalayova G, Ogrodnik A, Spencer B, Wade J, Bunn J, Ambaye A, et al. Human breast cancer biopsies induce eosinophil recruitment and enhance adjacent cancer cell proliferation. Breast Cancer Res Treat. 2016;157:461-74 pubmed publisher
  60. Rigden H, Alias A, Havelock T, O Donnell R, Djukanovic R, Davies D, et al. Squamous Metaplasia Is Increased in the Bronchial Epithelium of Smokers with Chronic Obstructive Pulmonary Disease. PLoS ONE. 2016;11:e0156009 pubmed publisher
  61. Hamam D, Abdouh M, Gao Z, Arena V, Arena M, Arena G. Transfer of malignant trait to BRCA1 deficient human fibroblasts following exposure to serum of cancer patients. J Exp Clin Cancer Res. 2016;35:80 pubmed publisher
  62. Fabbri R, Macciocca M, Vicenti R, Paradisi R, Klinger F, Pasquinelli G, et al. Doxorubicin and cisplatin induce apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue. Future Oncol. 2016;12:1699-711 pubmed publisher
  63. Terakawa J, Rocchi A, Serna V, Bottinger E, Graff J, Kurita T. FGFR2IIIb-MAPK Activity Is Required for Epithelial Cell Fate Decision in the Lower Müllerian Duct. Mol Endocrinol. 2016;30:783-95 pubmed publisher
  64. Hutter S, Knabl J, Andergassen U, Hofmann S, Kuhn C, Mahner S, et al. Placental Expression Patterns of Galectin-1, Galectin-2, Galectin-3 and Galectin-13 in Cases of Intrauterine Growth Restriction (IUGR). Int J Mol Sci. 2016;17:523 pubmed publisher
  65. Liang L, Huang H, Dadhania V, Zhang J, Zhang M, Liu J. Renal cell carcinoma metastatic to the ovary or fallopian tube: a clinicopathological study of 9 cases. Hum Pathol. 2016;51:96-102 pubmed publisher
  66. Fox K, Wootton S, Marolf A, Rouse N, LeVan I, Spraker T, et al. Experimental Transmission of Bighorn Sheep Sinus Tumors to Bighorn Sheep (Ovis canadensis canadensis) and Domestic Sheep. Vet Pathol. 2016;53:1164-1171 pubmed
  67. Graham R, Terracciano L, Meves A, Vanderboom P, Dasari S, Yeh M, et al. Hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas: both are characterized by LFABP loss. Mod Pathol. 2016;29:607-15 pubmed publisher
  68. Morrow C, Trapani F, Metcalf R, Bertolini G, Hodgkinson C, Khandelwal G, et al. Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study. Ann Oncol. 2016;27:1155-60 pubmed publisher
  69. Hes O, Condom Mundo E, Peckova K, Lopez J, Martinek P, Vanecek T, et al. Biphasic Squamoid Alveolar Renal Cell Carcinoma: A Distinctive Subtype of Papillary Renal Cell Carcinoma?. Am J Surg Pathol. 2016;40:664-75 pubmed publisher
  70. Wallingford M, Gammill H, Giachelli C. Slc20a2 deficiency results in fetal growth restriction and placental calcification associated with thickened basement membranes and novel CD13 and lamininα1 expressing cells. Reprod Biol. 2016;16:13-26 pubmed publisher
  71. Li H, Shen P, Liang Y, Zhang F. Fibroblastic reticular cell tumor of the breast: A case report and review of the literature. Exp Ther Med. 2016;11:561-564 pubmed
  72. Ambade A, Satishchandran A, Szabo G. Alcoholic hepatitis accelerates early hepatobiliary cancer by increasing stemness and miR-122-mediated HIF-1α activation. Sci Rep. 2016;6:21340 pubmed publisher
  73. Sundarkrishnan L, Bradish J, Oliai B, Hosler G. Cutaneous Cellular Pseudoglandular Schwannoma: An Unusual Histopathologic Variant. Am J Dermatopathol. 2016;38:315-8 pubmed publisher
  74. Guedj N, Vaquero J, Clapéron A, Mergey M, Chrétien Y, Paradis V, et al. Loss of ezrin in human intrahepatic cholangiocarcinoma is associated with ectopic expression of E-cadherin. Histopathology. 2016;69:211-21 pubmed publisher
  75. Guye P, Ebrahimkhani M, Kipniss N, Velazquez J, Schoenfeld E, Kiani S, et al. Genetically engineering self-organization of human pluripotent stem cells into a liver bud-like tissue using Gata6. Nat Commun. 2016;7:10243 pubmed publisher
  76. Böger C, Haag J, Egberts J, Röcken C. Complex APC germline mutation associated metaplasia and intraepithelial neoplasia (CAM-IEN) of the gallbladder. Pathol Res Pract. 2016;212:54-8 pubmed publisher
  77. Martínez Martínez M, Mosqueda Taylor A, Delgado Azañero W, Rumayor Piña A, de Almeida O. Primary intraosseous squamous cell carcinoma arising in an odontogenic keratocyst previously treated with marsupialization: case report and immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;121:e87-95 pubmed publisher
  78. Fleury H, Communal L, Carmona E, Portelance L, Arcand S, Rahimi K, et al. Novel high-grade serous epithelial ovarian cancer cell lines that reflect the molecular diversity of both the sporadic and hereditary disease. Genes Cancer. 2015;6:378-398 pubmed
  79. Shin H, Pei Z, Martinez K, Rivera Viñas J, Méndez K, Cavallin H, et al. The first microbial environment of infants born by C-section: the operating room microbes. Microbiome. 2015;3:59 pubmed publisher
  80. Vergne F, Quéré G, Andrieu Key S, Descourt R, Quintin Roué I, Talagas M, et al. ALK-rearranged squamous cell lung carcinoma responding to crizotinib: A missing link in the field of non-small cell lung cancer?. Lung Cancer. 2016;91:67-9 pubmed publisher
  81. Andreasen S, French C, Josiassen M, Hahn C, Kiss K. NUT Carcinoma of the Sublingual Gland. Head Neck Pathol. 2016;10:362-6 pubmed publisher
  82. van Jaarsveld M, van Kuijk P, Boersma A, Helleman J, Van Ijcken W, Mathijssen R, et al. miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway. Mol Cancer. 2015;14:196 pubmed publisher
  83. Gao L, Jiang Y, Mu L, Liu Y, Wang F, Wang P, et al. Efficient Generation of Mice with Consistent Transgene Expression by FEEST. Sci Rep. 2015;5:16284 pubmed publisher
  84. Jung M, Ryu Y, Kang G. Investigation of the origin of stromal and endothelial cells at the desmoplastic interface in xenograft tumor in mice. Pathol Res Pract. 2015;211:925-30 pubmed publisher
  85. Li Y, Adomat H, Guns E, Hojabrpour P, Duronio V, Curran T, et al. Identification of a Hematopoietic Cell Dedifferentiation-Inducing Factor. J Cell Physiol. 2016;231:1350-63 pubmed publisher
  86. Wu M, Si S, Li Y, Schoen S, Xiao G, Li X, et al. Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppression. Oncotarget. 2015;6:32761-73 pubmed publisher
  87. Chen Y, Chen H, Chien C, Wu S, Ho Y, Yu C, et al. Contribution of Mature Hepatocytes to Biliary Regeneration in Rats with Acute and Chronic Biliary Injury. PLoS ONE. 2015;10:e0134327 pubmed publisher
  88. Sauter J, Ambaye A, Mount S. Increased utilization, verification, and clinical implications of immunocytochemistry: Experience in a northern New England hospital. Diagn Cytopathol. 2015;43:688-95 pubmed publisher
  89. Liu K, Chuang S, Long C, Lee Y, Wang C, Lu M, et al. Ketamine-induced ulcerative cystitis and bladder apoptosis involve oxidative stress mediated by mitochondria and the endoplasmic reticulum. Am J Physiol Renal Physiol. 2015;309:F318-31 pubmed publisher
  90. Swaminathan T, Basheer V, Kumar R, Kathirvelpandian A, Sood N, Jena J. Establishment and characterization of fin-derived cell line from ornamental carp, Cyprinus carpio koi, for virus isolation in India. In Vitro Cell Dev Biol Anim. 2015;51:705-13 pubmed publisher
  91. Muhanna N, Mepham A, Mohamadi R, Chan H, Khan T, Akens M, et al. Nanoparticle-based sorting of circulating tumor cells by epithelial antigen expression during disease progression in an animal model. Nanomedicine. 2015;11:1613-20 pubmed publisher
  92. Yang E, Quick M, Hanamornroongruang S, Lai K, Doyle L, McKeon F, et al. Microanatomy of the cervical and anorectal squamocolumnar junctions: a proposed model for anatomical differences in HPV-related cancer risk. Mod Pathol. 2015;28:994-1000 pubmed publisher
  93. Kershaw S, Cummings J, Morris K, Tugwood J, Dive C. Optimisation of immunofluorescence methods to determine MCT1 and MCT4 expression in circulating tumour cells. BMC Cancer. 2015;15:387 pubmed publisher
  94. Katanov C, Lerrer S, Liubomirski Y, Leider Trejo L, Meshel T, Bar J, et al. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-? and the NF-?B pathway. Stem Cell Res Ther. 2015;6:87 pubmed publisher
  95. Aghababaei M, Hogg K, Perdu S, Robinson W, Beristain A. ADAM12-directed ectodomain shedding of E-cadherin potentiates trophoblast fusion. Cell Death Differ. 2015;22:1970-84 pubmed publisher
  96. Sood N, Chaudhary D, Pradhan P, Verma D, Raja Swaminathan T, Kushwaha B, et al. Establishment and characterization of a continuous cell line from thymus of striped snakehead, Channa striatus (Bloch 1793). In Vitro Cell Dev Biol Anim. 2015;51:787-96 pubmed publisher
  97. Li X, Tao J, Cigliano A, Sini M, Calderaro J, Azoulay D, et al. Co-activation of PIK3CA and Yap promotes development of hepatocellular and cholangiocellular tumors in mouse and human liver. Oncotarget. 2015;6:10102-15 pubmed
  98. Aguiar C, Therrien J, Lemire P, Segura M, Smith L, Theoret C. Differentiation of equine induced pluripotent stem cells into a keratinocyte lineage. Equine Vet J. 2016;48:338-45 pubmed publisher
  99. Chen Q, Gu Y, Liu B. Clinicopathological characteristics of kidney mucinous tubular and spindle cell carcinoma. Int J Clin Exp Pathol. 2015;8:1007-12 pubmed
  100. Ahmed H, Abdul Gader Suliman R, Abd El Aziz M, Alshammari F. Immunohistochemical expression of cytokeratins and epithelial membrane protein 2 in nasopharyngeal carcinoma and its potential implications. Asian Pac J Cancer Prev. 2015;16:653-6 pubmed
  101. Zheng L, Cardaci S, Jerby L, MacKenzie E, Sciacovelli M, Johnson T, et al. Fumarate induces redox-dependent senescence by modifying glutathione metabolism. Nat Commun. 2015;6:6001 pubmed publisher
  102. Petrosyan A, Ali M, Cheng P. Keratin 1 plays a critical role in golgi localization of core 2 N-acetylglucosaminyltransferase M via interaction with its cytoplasmic tail. J Biol Chem. 2015;290:6256-69 pubmed publisher
  103. Schotanus B, Kruitwagen H, van den Ingh T, van Wolferen M, Rothuizen J, Penning L, et al. Enhanced Wnt/β-catenin and Notch signalling in the activated canine hepatic progenitor cell niche. BMC Vet Res. 2014;10:309 pubmed publisher
  104. Progatzky F, Sangha N, Yoshida N, McBrien M, Cheung J, Shia A, et al. Dietary cholesterol directly induces acute inflammasome-dependent intestinal inflammation. Nat Commun. 2014;5:5864 pubmed publisher
  105. Almeida B, Bacchi C, Carvalho J, Ferreira C, Carvalho F. The role of intratumoral lymphovascular density in distinguishing primary from secondary mucinous ovarian tumors. Clinics (Sao Paulo). 2014;69:660-5 pubmed publisher
  106. Moser B, Schiefer A, Janik S, Marx A, Prosch H, Pohl W, et al. Adenocarcinoma of the thymus, enteric type: report of 2 cases, and proposal for a novel subtype of thymic carcinoma. Am J Surg Pathol. 2015;39:541-8 pubmed publisher
  107. Suzuki D, Sahu R, Leu N, Senoo M. The carboxy-terminus of p63 links cell cycle control and the proliferative potential of epidermal progenitor cells. Development. 2015;142:282-90 pubmed publisher
  108. Smid J, Faulkes S, Rudnicki M. Periostin induces pancreatic regeneration. Endocrinology. 2015;156:824-36 pubmed publisher
  109. Groisman G, Depsames R, Ovadia B, Meir A. Metastatic carcinoma occurring in a gastric hyperplastic polyp mimicking primary gastric cancer: the first reported case. Case Rep Pathol. 2014;2014:781318 pubmed publisher
  110. Raap M, Antonopoulos W, Dämmrich M, Christgen H, Steinmann D, Länger F, et al. High frequency of lobular breast cancer in distant metastases to the orbit. Cancer Med. 2015;4:104-11 pubmed publisher
  111. Beck A, Brooks A, Zeiss C. Invasive ductular carcinoma in 2 rhesus macaques (Macaca mulatta). Comp Med. 2014;64:314-22 pubmed
  112. Lu H, Clauser K, Tam W, Fröse J, Ye X, Eaton E, et al. A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages. Nat Cell Biol. 2014;16:1105-17 pubmed publisher
  113. Baccelli I, Stenzinger A, Vogel V, Pfitzner B, Klein C, Wallwiener M, et al. Co-expression of MET and CD47 is a novel prognosticator for survival of luminal breast cancer patients. Oncotarget. 2014;5:8147-60 pubmed
  114. Li L, Fan X, Xia Q, Rao Q, Liu B, Yu B, et al. Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: implications for the cocontributions of multiple SWI/SNF complex members to pathogenesis. Hum Pathol. 2014;45:2247-54 pubmed publisher
  115. Costache M, Pătraşcu O, Dumitru A, Costache D, Voinea L, Simionescu O, et al. Histopathological findings concerning ocular melanomas. Rom J Morphol Embryol. 2014;55:649-53 pubmed
  116. Thompson L, Bauer J, Chiosea S, McHugh J, Seethala R, Miettinen M, et al. Canalicular adenoma: a clinicopathologic and immunohistochemical analysis of 67 cases with a review of the literature. Head Neck Pathol. 2015;9:181-95 pubmed publisher
  117. Guan H, Tan J, Zhang F, Gao L, Bai L, Qi D, et al. Myofibroblasts from salivary gland adenoid cystic carcinomas promote cancer invasion by expressing MMP2 and CXCL12. Histopathology. 2015;66:781-90 pubmed publisher
  118. Chang W, Yang Q, Zhang H, Lin H, Zhou Z, Lu X, et al. Role of placenta-specific protein 1 in trophoblast invasion and migration. Reproduction. 2014;148:343-52 pubmed publisher
  119. Rizvi S, Mertens J, Bronk S, Hirsova P, Dai H, Roberts L, et al. Platelet-derived growth factor primes cancer-associated fibroblasts for apoptosis. J Biol Chem. 2014;289:22835-49 pubmed publisher
  120. Francis V, Abera A, Matjila M, Millar R, Katz A. Kisspeptin regulation of genes involved in cell invasion and angiogenesis in first trimester human trophoblast cells. PLoS ONE. 2014;9:e99680 pubmed publisher
  121. Oishi N, Kondo T, Nakazawa T, Mochizuki K, Kasai K, Inoue T, et al. Thyroid-like low-grade nasopharyngeal papillary adenocarcinoma: case report and literature review. Pathol Res Pract. 2014;210:1142-5 pubmed publisher
  122. Velicky P, Haider S, Otti G, Fiala C, Pollheimer J, Knöfler M. Notch-dependent RBPJ? inhibits proliferation of human cytotrophoblasts and their differentiation into extravillous trophoblasts. Mol Hum Reprod. 2014;20:756-66 pubmed publisher
  123. Capella C, Marando A, Longhi E, Bernasconi B, Finzi G, Parravicini C, et al. Primary gastric Merkel cell carcinoma harboring DNA polyomavirus: first description of an unusual high-grade neuroendocrine carcinoma. Hum Pathol. 2014;45:1310-4 pubmed publisher
  124. Biadasiewicz K, Fock V, Dekan S, Proestling K, Velicky P, Haider S, et al. Extravillous trophoblast-associated ADAM12 exerts pro-invasive properties, including induction of integrin beta 1-mediated cellular spreading. Biol Reprod. 2014;90:101 pubmed publisher
  125. Lee J, Lee M. Decreased expression of zonula occludens-1 and occludin in the bladder urothelium of patients with interstitial cystitis/painful bladder syndrome. J Formos Med Assoc. 2014;113:17-22 pubmed publisher
  126. Dadone B, Ambrosetti D, Carpentier X, Duranton Tanneur V, Burel Vandenbos F, Amiel J, et al. A renal metanephric adenoma showing both a 2p16e24 deletion and BRAF V600E mutation: a synergistic role for a tumor suppressor gene on chromosome 2p and BRAF activation?. Cancer Genet. 2013;206:347-52 pubmed
  127. Karaca G, Swiderska Syn M, Xie G, Syn W, Krüger L, Machado M, et al. TWEAK/Fn14 signaling is required for liver regeneration after partial hepatectomy in mice. PLoS ONE. 2014;9:e83987 pubmed publisher
  128. Motomura K, Sumino H, Noguchi A, Horinouchi T, Nakanishi K. Sentinel nodes identified by computed tomography-lymphography accurately stage the axilla in patients with breast cancer. BMC Med Imaging. 2013;13:42 pubmed publisher
  129. Jones H, Gold M, Giannico G, Troutman A, Vnencak Jones C, Schultenover S, et al. Lymphoepithelioma-like carcinoma of the endometrium: immunophenotypic characterization of a rare tumor with microsatellite instability testing. Int J Gynecol Pathol. 2014;33:64-73 pubmed publisher
  130. Elakoum R, Gauchotte G, Oussalah A, Wissler M, Clément Duchêne C, Vignaud J, et al. CARM1 and PRMT1 are dysregulated in lung cancer without hierarchical features. Biochimie. 2014;97:210-8 pubmed publisher
  131. Bulysheva A, Bowlin G, Petrova S, Yeudall W. Enhanced chemoresistance of squamous carcinoma cells grown in 3D cryogenic electrospun scaffolds. Biomed Mater. 2013;8:055009 pubmed publisher
  132. Kusafuka K, Onitsuka T, Muramatsu K, Miki T, Murai C, Suda T, et al. Salivary duct carcinoma with rhabdoid features: report of 2 cases with immunohistochemical and ultrastructural analyses. Head Neck. 2014;36:E28-35 pubmed publisher
  133. Yousem S. Immunohistochemical and molecular characterization of clear cell carcinoma of the lung. Hum Pathol. 2013;44:2467-74 pubmed publisher
  134. Motomura K, Izumi T, Tateishi S, Sumino H, Noguchi A, Horinouchi T, et al. Correlation between the area of high-signal intensity on SPIO-enhanced MR imaging and the pathologic size of sentinel node metastases in breast cancer patients with positive sentinel nodes. BMC Med Imaging. 2013;13:32 pubmed publisher
  135. Lim R, Barker G, Lappas M. TREM-1 expression is increased in human placentas from severe early-onset preeclamptic pregnancies where it may be involved in syncytialization. Reprod Sci. 2014;21:562-72 pubmed publisher
  136. Qiu S, Wei X, Huang W, Wu M, Qin Y, Li Y, et al. Diagnostic and therapeutic strategy and the most efficient prognostic factors of breast malignant fibrous histiocytoma. Sci Rep. 2013;3:2529 pubmed publisher
  137. Li X, Feng Y, Wei W, Liu P, Xie Z, Wang J, et al. Signet-ring cell carcinoma of the breast: a case report. World J Surg Oncol. 2013;11:183 pubmed publisher
  138. Hosokawa M, Kenmotsu H, Koh Y, Yoshino T, Yoshikawa T, Naito T, et al. Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system. PLoS ONE. 2013;8:e67466 pubmed publisher
  139. Ohta K, Taki M, Ogawa I, Ono S, Mizuta K, Fujimoto S, et al. Malignant ossifying fibromyxoid tumor of the tongue: case report and review of the literature. Head Face Med. 2013;9:16 pubmed publisher
  140. Nassiri F, Scheithauer B, Corwin D, Kaplan H, Mayberg M, Cusimano M, et al. Invasive thymoma metastatic to the cavernous sinus. Surg Neurol Int. 2013;4:74 pubmed publisher
  141. Yang G, Li J, Jin H, Ding H. Is mammary not otherwise specified-type sarcoma with CD10 expression a distinct entity? A rare case report with immunohistochemical and ultrastructural study. Diagn Pathol. 2013;8:14 pubmed publisher
  142. Iyer S, Dange P, Alam H, Sawant S, Ingle A, Borges A, et al. Understanding the role of keratins 8 and 18 in neoplastic potential of breast cancer derived cell lines. PLoS ONE. 2013;8:e53532 pubmed publisher
  143. Weli S, Aamelfot M, Dale O, Koppang E, Falk K. Infectious salmon anaemia virus infection of Atlantic salmon gill epithelial cells. Virol J. 2013;10:5 pubmed publisher
  144. Tang Z, Niven Fairchild T, Tadesse S, Norwitz E, Buhimschi C, Buhimschi I, et al. Glucocorticoids enhance CD163 expression in placental Hofbauer cells. Endocrinology. 2013;154:471-82 pubmed publisher
  145. Lv S, Song Y, Xu J, Shu H, Zhou Z, An N, et al. A novel TP53 somatic mutation involved in the pathogenesis of pediatric choroid plexus carcinoma. Med Sci Monit. 2012;18:CS37-41 pubmed
  146. Sohn W, Gwon G, An C, Moon C, Bae Y, Yamamoto H, et al. Morphological evidences in circumvallate papilla and von Ebners' gland development in mice. Anat Cell Biol. 2011;44:274-83 pubmed publisher
  147. Khoja L, Backen A, Sloane R, Menasce L, Ryder D, Krebs M, et al. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br J Cancer. 2012;106:508-16 pubmed publisher
  148. Kap M, Smedts F, Oosterhuis W, Winther R, Christensen N, Reischauer B, et al. Histological assessment of PAXgene tissue fixation and stabilization reagents. PLoS ONE. 2011;6:e27704 pubmed publisher
  149. Errasti Murugarren E, Diaz P, Godoy V, Riquelme G, Pastor Anglada M. Expression and distribution of nucleoside transporter proteins in the human syncytiotrophoblast. Mol Pharmacol. 2011;80:809-17 pubmed publisher
  150. Brusevold I, Husvik C, Schreurs O, Schenck K, Bryne M, Søland T. Induction of invasion in an organotypic oral cancer model by CoCl2, a hypoxia mimetic. Eur J Oral Sci. 2010;118:168-76 pubmed publisher
  151. Gauster M, Siwetz M, Huppertz B. Fusion of villous trophoblast can be visualized by localizing active caspase 8. Placenta. 2009;30:547-50 pubmed publisher
  152. Gil da Costa R, Santos M, Amorim I, Lopes C, Pereira P, Faustino A. An immunohistochemical study of feline endometrial adenocarcinoma. J Comp Pathol. 2009;140:254-9 pubmed publisher
  153. Rhee K, Wu S, Wu X, Huso D, Karim B, Franco A, et al. Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice. Infect Immun. 2009;77:1708-18 pubmed publisher
  154. Ryan P, Nguyen V, Gholoum S, Carpineta L, Abish S, Ahmed N, et al. Polypoid PEComa in the rectum of a 15-year-old girl: case report and review of PEComa in the gastrointestinal tract. Am J Surg Pathol. 2009;33:475-82 pubmed publisher
  155. Rodriguez F, Scheithauer B, Giannini C, Bryant S, Jenkins R. Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study. Cancer. 2008;113:2779-89 pubmed publisher
  156. Lu S, Yu G, Zhu Y, Archer M. Cyclooxygenase-2 overexpression in MCF-10F human breast epithelial cells inhibits proliferation, apoptosis and differentiation, and causes partial transformation. Int J Cancer. 2005;116:847-52 pubmed
  157. Gilbert S, Loranger A, Marceau N. Keratins modulate c-Flip/extracellular signal-regulated kinase 1 and 2 antiapoptotic signaling in simple epithelial cells. Mol Cell Biol. 2004;24:7072-81 pubmed
  158. Song S, Park S, Kim S, Suh Y. Oncocytic adrenocortical carcinomas: a pathological and immunohistochemical study of four cases in comparison with conventional adrenocortical carcinomas. Pathol Int. 2004;54:603-10 pubmed
  159. Kokenyesi R, Murray K, Benshushan A, Huntley E, Kao M. Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression. Gynecol Oncol. 2003;89:60-72 pubmed